JPWO2020247418A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020247418A5 JPWO2020247418A5 JP2021571941A JP2021571941A JPWO2020247418A5 JP WO2020247418 A5 JPWO2020247418 A5 JP WO2020247418A5 JP 2021571941 A JP2021571941 A JP 2021571941A JP 2021571941 A JP2021571941 A JP 2021571941A JP WO2020247418 A5 JPWO2020247418 A5 JP WO2020247418A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- oxyphenyl
- cyclopropane
- fluorophenyl
- dicarboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856920P | 2019-06-04 | 2019-06-04 | |
| US62/856,920 | 2019-06-04 | ||
| PCT/US2020/035808 WO2020247418A1 (en) | 2019-06-04 | 2020-06-03 | Compounds for the treatment of kinase-dependent disorders |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022535108A JP2022535108A (ja) | 2022-08-04 |
| JP2022535108A5 JP2022535108A5 (https=) | 2023-06-12 |
| JPWO2020247418A5 true JPWO2020247418A5 (https=) | 2023-06-12 |
| JP7820152B2 JP7820152B2 (ja) | 2026-02-25 |
Family
ID=71842789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571941A Active JP7820152B2 (ja) | 2019-06-04 | 2020-06-03 | キナーゼ依存性障害の処置のための化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12503438B2 (https=) |
| EP (1) | EP3980404A1 (https=) |
| JP (1) | JP7820152B2 (https=) |
| CN (1) | CN114040912B (https=) |
| AR (1) | AR119069A1 (https=) |
| AU (1) | AU2020289324B2 (https=) |
| CA (1) | CA3139156A1 (https=) |
| MA (1) | MA56114A (https=) |
| TW (1) | TWI850394B (https=) |
| WO (1) | WO2020247418A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA128476C2 (uk) * | 2018-01-26 | 2024-07-24 | Екселіксіс, Інк. | Сполуки для лікування кіназозалежних розладів |
| CN114573553B (zh) * | 2022-01-27 | 2023-11-10 | 广州六顺生物科技有限公司 | 杂芳环类衍生物及其制备方法和应用 |
| CN114605391B (zh) * | 2022-02-21 | 2024-01-26 | 广州六顺生物科技股份有限公司 | 喹喔啉类衍生物及其制备方法和应用 |
| CN116271008A (zh) * | 2022-12-30 | 2023-06-23 | 广东天普生化医药股份有限公司 | 含有安柯瑞和卡瑞利珠单抗的药物组合物及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2213661E (pt) | 2003-09-26 | 2011-12-15 | Exelixis Inc | Moduladores de c-met e métodos de uso |
| WO2006113546A2 (en) | 2005-04-15 | 2006-10-26 | Neogenix Oncology, Inc. | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| JP2009526761A (ja) * | 2006-01-30 | 2009-07-23 | アレイ バイオファーマ、インコーポレイテッド | ヘテロ二環式チオフェン化合物および使用の方法 |
| EP2423208A1 (en) | 2010-08-28 | 2012-02-29 | Lead Discovery Center GmbH | Pharmaceutically active compounds as Axl inhibitors |
| US8664244B2 (en) * | 2010-09-12 | 2014-03-04 | Advenchen Pharmaceuticals, LLC | Compounds as c-Met kinase inhibitors |
| CA2886433C (en) | 2012-10-04 | 2022-01-04 | Dana-Farber Cancer Institute, Inc. | Human monoclonal anti-pd-l1 antibodies and methods of use |
| JP6742903B2 (ja) | 2013-05-02 | 2020-08-19 | アナプティスバイオ インコーポレイティッド | プログラム死−１（ｐｄ−１）に対する抗体 |
| IL248408B (en) * | 2014-04-25 | 2022-06-01 | Exelixis Inc | A method for treating adenocarcinoma of the lungs |
| CN104817497B (zh) * | 2015-03-20 | 2017-03-08 | 南京众睿缘生物科技有限公司 | 一种炔代喹啉衍生物及其制备方法和用途 |
| CN106279147A (zh) | 2015-05-21 | 2017-01-04 | 中国科学院上海药物研究所 | 一种吡啶并氮杂环化合物及其制备方法和用途 |
| CN107235896B (zh) * | 2016-09-13 | 2019-11-05 | 上海翔锦生物科技有限公司 | 酪氨酸激酶抑制剂及其应用 |
| SG11202005719UA (en) | 2017-12-20 | 2020-07-29 | Angex Pharmaceutical Inc | Carbamate and urea compounds as multikinase inhibitors |
| UA128476C2 (uk) * | 2018-01-26 | 2024-07-24 | Екселіксіс, Інк. | Сполуки для лікування кіназозалежних розладів |
| US10829486B2 (en) | 2018-02-14 | 2020-11-10 | Enanta Pharmacueticals, Inc. | Isoxazole derivatives as FXR agonists and methods of use thereof |
-
2020
- 2020-06-02 AR ARP200101554A patent/AR119069A1/es unknown
- 2020-06-03 AU AU2020289324A patent/AU2020289324B2/en active Active
- 2020-06-03 MA MA056114A patent/MA56114A/fr unknown
- 2020-06-03 US US17/616,120 patent/US12503438B2/en active Active
- 2020-06-03 JP JP2021571941A patent/JP7820152B2/ja active Active
- 2020-06-03 EP EP20747207.7A patent/EP3980404A1/en active Pending
- 2020-06-03 CN CN202080048050.0A patent/CN114040912B/zh active Active
- 2020-06-03 CA CA3139156A patent/CA3139156A1/en active Pending
- 2020-06-03 WO PCT/US2020/035808 patent/WO2020247418A1/en not_active Ceased
- 2020-06-04 TW TW109118785A patent/TWI850394B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018522859A5 (https=) | ||
| JP2016519096A5 (https=) | ||
| IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| AU2020282473A1 (en) | Nitrogen-containing heterocyclic derivative regulator, preparation method therefor and application thereof | |
| JP2014518214A5 (https=) | ||
| ME02416B (me) | Trpv4 antagonisтi | |
| RU2017105296A (ru) | Новые соединения | |
| JP2017530960A5 (https=) | ||
| CA2515197A1 (en) | Pyrazolopyridine derivates | |
| CA2592986A1 (en) | Heteroaromatic quinoline compounds | |
| JP2014528446A5 (https=) | ||
| JP2019504821A5 (https=) | ||
| JP2014521711A5 (https=) | ||
| JP2019530695A5 (https=) | ||
| RU2015114936A (ru) | Ингибиторы серин/треонинкиназы | |
| HRP20211957T1 (hr) | Analozi 1,4-disupstituiranog piridazina i postupci za liječenje stanja povezanih s nedostatkom smn | |
| WO2021134004A1 (en) | Cyclic compounds and methods of using same | |
| JP2015500332A5 (https=) | ||
| JP2015526452A5 (https=) | ||
| JP2007504148A5 (https=) | ||
| JP2016507551A5 (https=) | ||
| JP2011529959A5 (https=) | ||
| RU2019116251A (ru) | Пиразоло[3,4-b]пиридины и имидазо[1,5-b]пиридазины в качестве ингибиторов pde1 | |
| JPWO2021021986A5 (https=) | ||
| JPWO2020247418A5 (https=) |